|
Q |
Klgr1 |
Kidney lesion grade QTL 1 |
|
IDA |
|
RGD |
PMID:16534143 |
RGD:1578520 |
NCBI chr 8:30,848,154...101,699,754
|
|
Q |
Rends2 |
Renal damage susceptibility QTL 2 |
|
IDA |
renal vascular damage |
RGD |
PMID:12874092 |
RGD:631854 |
NCBI chr 1:19,333,571...56,983,283
|
|
Q |
Rends3 |
Renal damage susceptibility QTL 3 |
|
IDA |
renal vascular damage |
RGD |
PMID:12874092 |
RGD:631854 |
NCBI chr10:79,813,789...85,160,854
|
|
Q |
Rends4 |
Renal damage susceptibility QTL 4 |
|
IDA |
renal vascular damage |
RGD |
PMID:12874092 |
RGD:631854 |
NCBI chr16:1...26,727,669
|
|
|
Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
|
|
|
Q |
Prcr1 |
Prostate cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 2:114,440,891...159,440,891
|
|
Q |
Prcr2 |
Prostate cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 1:10,379,492...55,379,492
|
|
|
Q |
Bp49 |
Blood pressure QTL 49 |
|
IDA |
|
RGD |
PMID:9241273 |
RGD:61056 |
NCBI chr 5:60,293,434...98,603,051
|
|
|
Q |
Glom10 |
Glomerulus QTL 10 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr11:3,818,154...48,818,154
|
|
Q |
Glom11 |
Glomerulus QTL 11 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr18:53,266,671...86,134,022
|
|
Q |
Glom12 |
Glomerulus QTL 12 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr 5:38,011,670...83,011,670
|
|
Q |
Glom13 |
Glomerulus QTL 13 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
|
|
Q |
Glom14 |
Glomerulus QTL 14 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr15:40,463,152...85,463,152
|
|
Q |
Glom17 |
Glomerulus QTL 17 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr 1:175,967,553...200,707,874
|
|
Q |
Glom18 |
Glomerulus QTL 18 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr 1:194,786,607...262,083,703
|
|
Q |
Glom19 |
Glomerulus QTL 19 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
|
|
Q |
Glom20 |
Glomerulus QTL 20 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr11:57,754,837...96,071,021
|
|
Q |
Glom21 |
Glomerulus QTL 21 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr18:5,460,455...42,690,191
|
|
Q |
Glom9 |
Glomerulus QTL 9 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
|
|
Q |
Rends1 |
Renal damage susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10454439 |
RGD:632218 |
NCBI chr 1:139,442,053...223,964,440
|
|
Q |
Rf57 |
Renal function QTL 57 |
|
IDA |
|
RGD |
PMID:19584172 |
RGD:2316856 |
NCBI chr 5:59,793,528...90,450,144
|
|
Q |
Rf58 |
Renal function QTL 58 |
|
IDA |
|
RGD |
PMID:19584172 |
RGD:2316856 |
NCBI chr 7:68,938,720...113,886,318
|
|
Q |
Rf9 |
Renal function QTL 9 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 2:113,746,222...205,135,428
|
|
|
Q |
Glom27 |
Glomerulus QTL 27 |
|
IDA |
|
RGD |
PMID:22445570 |
RGD:7207870 |
NCBI chr13:21,120,177...109,350,286
|
|
|
Q |
Glom15 |
Glomerulus QTL 15 |
|
IDA |
|
RGD |
PMID:16482158 |
RGD:2293335 |
NCBI chr13:67,635,937...109,350,286
|
|
Q |
Glom16 |
Glomerulus QTL 16 |
|
IDA |
|
RGD |
PMID:16482158 |
RGD:2293335 |
NCBI chr16:839,086...52,786,090
|
|
Q |
Glom24 |
Glomerulus QTL 24 |
|
IDA |
|
RGD |
PMID:16482158 |
RGD:2293335 |
NCBI chr 5:141,764,300...172,190,305
|
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:51,464,733...83,218,561
|
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...32,584,199
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,057,237...83,368,335
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,266,368...46,921,453
|
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...41,244,106
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...42,356,786
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:59,874,408...85,581,182
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:74,862,117...85,581,182
|
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:34,293,282...79,293,282
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:233,948,574...260,522,016
|
|
|
Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:70,808,386...115,808,386
|
|
Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:123,143,783...168,143,783
|
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:40,713,066...82,925,667
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:82,523,650...110,548,006
|
|
Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
IDA |
|
RGD |
PMID:15771619 |
RGD:1358145 |
NCBI chr 1:153,136,852...260,522,016
|
|
Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:214,537,555...226,660,468
|
|
Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:70,808,386...115,808,386
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:5,925,874...115,540,829
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:176,426,412...257,976,495
|
|
Q |
Hcas8 |
Hepatocarcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:17079458 |
RGD:1599590 |
NCBI chr16:1...22,477,621
|
|
|
Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:193,422,268...214,537,671
|
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:91,412,594...129,807,172
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:144,267,353...222,987,745
|
|
|
Q |
Mamtr7 |
Mammary tumor resistance QTL 7 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr10:9,658,275...104,670,812
|
|
Q |
Mamtr8 |
Mammary tumor resistance QTL 8 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,359,408...83,218,561
|
|
Q |
Mcs20 |
Mammary carcinoma susceptibility QTL 20 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 9:13,533,770...42,791,750
|
|
Q |
Mcs21 |
Mammary carcinoma susceptibility QTL 21 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr10:28,875,650...52,200,160
|
|
Q |
Mcs22 |
Mammary carcinoma susceptibility QTL 22 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr18:52,539,763...63,933,058
|
|
|
Q |
Mcs31 |
Mammary carcinoma susceptibility QTL 31 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 9:77,813,894...111,552,878
|
|
Q |
Mcs32 |
Mammary carcinoma susceptibility QTL 32 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 1:115,540,693...238,914,717
|
|
Q |
Mcs33 |
Mammary carcinoma susceptibility QTL 33 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 5:131,345,754...166,875,058
|
|
Q |
Mcs34 |
Mammary carcinoma susceptibility QTL 34 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
|
|
|
Q |
Emca11 |
Estrogen-induced mammary cancer QTL 11 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:99,753,548...113,061,097
|
|
Q |
Emca12 |
Estrogen-induced mammary cancer QTL 12 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:124,160,767...133,749,643
|
|
Q |
Emca13 |
Estrogen-induced mammary cancer QTL 13 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:9,823,266...99,753,708
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:44,463,720...155,883,716
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:15,107,216...107,351,382
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:50,328,551...141,643,988
|
|
Q |
Mamtr1 |
Mammary tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:12844486 |
RGD:631852 |
NCBI chr 5:12,789,751...113,558,310
|
|
Q |
Mamtr2 |
Mammary tumor resistance QTL 2 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:7,887,772...12,654,247
|
|
Q |
Mamtr3 |
Mammary tumor resistance QTL 3 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:32,373,770...43,665,178
|
|
Q |
Mamtr4 |
Mammary tumor resistance QTL 4 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:16,491,740...61,491,740
|
|
Q |
Mamtr5 |
Mammary tumor resistance QTL 5 |
|
IDA |
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:18,873,947...63,873,947
|
|
Q |
Mamtr6 |
Mammary tumor resistance QTL 6 |
|
IDA |
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,278,901...83,218,561
|
|
Q |
Mcs1 |
Mammary carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:7,887,772...23,319,447
|
|
Q |
Mcs12 |
Mammary carcinoma susceptibility QTL 12 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:58,973,449...60,051,321
|
|
Q |
Mcs13 |
Mammary carcinoma susceptibility QTL 13 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:63,190,890...69,927,503
|
|
Q |
Mcs14 |
Mammary carcinoma susceptibility QTL 14 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:76,369,776...80,813,390
|
|
Q |
Mcs15 |
Mammary carcinoma susceptibility QTL 15 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:85,565,469...103,884,409
|
|
Q |
Mcs16 |
Mammary carcinoma susceptibility QTL 16 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:2,244,390...43,433,040
|
|
Q |
Mcs17 |
Mammary carcinoma susceptibility QTL 17 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:197,670,404...242,670,404
|
|
Q |
Mcs18 |
Mammary carcinoma susceptibility QTL 18 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 2:7,887,772...42,804,738
|
|
Q |
Mcs19 |
Mammary carcinoma susceptibility QTL 19 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 5:99,485,997...103,690,167
|
|
Q |
Mcs2 |
Mammary carcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:19,032,807...35,526,300
|
|
Q |
Mcs23 |
Mammary carcinoma susceptibility QTL 23 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q |
Mcs24 |
Mammary carcinoma susceptibility QTL 24 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:64,719,390...109,719,390
|
|
Q |
Mcs28 |
Mammary carcinoma susceptibility QTL 28 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,743,239...78,039,084
|
|
Q |
Mcs29 |
Mammary carcinoma susceptibility QTL 29 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,816,155...77,988,860
|
|
Q |
Mcs3 |
Mammary carcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:102,268,556...147,268,556
|
|
Q |
Mcs30 |
Mammary carcinoma susceptibility QTL 30 |
|
IDA |
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:797,729...8,525,593
|
|
Q |
Mcs4 |
Mammary carcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:16,290,444...61,290,444
|
|
Q |
Mcs5 |
Mammary carcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:55,805,606...132,207,589
|
|
Q |
Mcs6 |
Mammary carcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:26,737,401...63,902,784
|
|
Q |
Mcs7 |
Mammary carcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,224,939...107,211,142
|
|
Q |
Mcs8 |
Mammary carcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,813,074...24,531,477
|
|
Q |
Mcsm1 |
Mammary carcinoma susceptibility modifier QTL 1 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:58,632,962...103,632,962
|
|
|
Q |
Tcas10 |
Tongue tumor susceptibility QTL 10 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr10:31,297,439...76,297,439
|
|
Q |
Tcas11 |
Tongue tumor susceptibility QTL 11 |
|
IDA |
|
RGD |
PMID:16527513 |
RGD:1578522 |
NCBI chr 5:46,711,509...161,317,411
|
|
Q |
Tcas2 |
Tongue tumor susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:192,485,903...199,050,587
|
|
Q |
Tcas3 |
Tongue tumor susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 4:10,814,170...91,360,527
|
|
Q |
Tcas4 |
Tongue tumor susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr14:17,622,561...42,337,007
|
|
Q |
Tcas5 |
Tongue tumor susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr19:9,977,753...39,654,489
|
|
Q |
Tcas6 |
Tongue tumor susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:92,948,896...144,267,916
|
|
Q |
Tcas8 |
Tongue tumor susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
Q |
Tcas9 |
Tongue tumor susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 6:1...37,618,905
|
|
|
Q |
Tcat1 |
Tongue tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr 1:99,267,916...144,267,916
|
|
|
Q |
Pancm1 |
Pancreatic morphology QTL 1 |
|
IDA |
|
RGD |
PMID:9169130 |
RGD:61083 |
NCBI chr 1:181,759,564...214,537,555
|
|
|
Q |
Strs4 |
Sensitivity to stroke QTL 4 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr 1:78,430,536...123,430,536
|
|
Q |
Strs5 |
Sensitivity to stroke QTL 5 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr18:49,999,958...65,845,095
|
|
Q |
Strs6 |
Sensitivity to stroke QTL 6 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr 5:134,972,980...138,113,556
|
|
Q |
Strs7 |
Sensitivity to stroke QTL 7 |
|
IDA |
|
RGD |
PMID:23690346 |
RGD:7411685 |
NCBI chr15:40,289,901...49,308,583
|
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:43,827,364...169,034,231
|
|
|
Q |
Tls2 |
T-lymphoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:80,221,299...109,401,111
|
|
Q |
Tls3 |
T-lymphoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:51,774,612...95,600,334
|
|
|
Q |
Tescar1 |
Testicular tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:34,618,760...79,618,760
|
|
|
Q |
Schws1 |
Schwannoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr10:40,035,094...102,359,817
|
|
Q |
Schws2 |
Schwannoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
|
|
Q |
Schws3 |
Schwannoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 3:118,839,124...163,839,124
|
|
Q |
Schws4 |
Schwannoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 6:83,190,345...106,747,639
|
|
Q |
Schws7 |
Schwannoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr10:4,765,527...19,816,042
|
|
Q |
Schws8 |
Schwannoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:94,968,928...139,968,928
|
|
Q |
Schws9 |
Schwannoma susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:61,747,639...106,747,639
|
|
|
Q |
Prcs1 |
Prostate cancer susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr19:31,287,532...51,431,640
|
|
Q |
Prcs2 |
Prostate cancer susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr20:1...34,066,551
|
|
|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:99,216,724...148,607,142
|
|
Q |
Emca10 |
Estrogen-induced mammary cancer QTL 10 |
|
IDA |
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 6:16,536,140...61,536,140
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:18,007,599...63,571,040
|
|
Q |
Mcs26 |
Mammary carcinoma susceptibility QTL 26 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:106,752,656...132,339,866
|
|
Q |
Mcs27 |
Mammary carcinoma susceptibility QTL 27 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:43,437,904...47,841,255
|
|
|
Q |
Strs1 |
Sensitivity to stroke QTL 1 |
|
IDA |
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 1:121,767,634...166,767,634
|
|
Q |
Strs2 |
Sensitivity to stroke QTL 2 |
|
IDA |
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 5:135,929,696...166,875,058
|
|
Q |
Strs3 |
Sensitivity to stroke QTL 3 |
|
IDA |
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 4:40,433,388...85,433,388
|
|
|
Q |
Tcas1 |
Tongue tumor susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr19:2,316,121...47,316,121
|
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,696,791...82,635,055
|
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,696,791...82,635,055
|
|
|
Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:120,260,281...147,278,687
|
|
Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:8,658,162...27,494,778
|
|
Q |
Gcs1 |
Gastric cancer susceptibility QTL1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:76,306,099...101,769,107
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,154,182...15,990,232
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:29,463,235...118,376,539
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:78,878,504...123,878,504
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:54,237,644...99,103,503
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:109,866,907...167,139,601
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,227,609...46,975,965
|
|